It explores several treatment options for type 1 diabetes in the country such as insulin therapy, conventional insulin therapy and multiple daily injections (MDI) or intensive insulin therapy. It discusses the role of socioeconomic factors in determining the access of Kenyans to various health ...
Introduction: The expanding variety of insulins, including biosynthetic human insulin and rapid and long-acting insulin analogs, have dramatically transformed the management of type 1 diabetes (T1D) over the past 25 years. Moreover, increasing interest in the use of novel drugs developed for the ...
Type 1 diabetes currently is a lifelong disease. People with type 1 diabetes need regular checkups. They must carefully monitor their blood sugar levels every day. They must receive insulin treatment throughout life. A small number of people can become exceptions to this rule. Some people with ...
Type 1 diabetes cannot be cured, but it can be managed.DISCHARGE INSTRUCTIONS:Return to the emergency department if:Your child has a low blood sugar level and it does not improve with treatment. Your child's blood sugar level is above 240 mg/dL and does not come down after a dose of ...
Food and Drug Administration for the treatment of type 2 diabetes in youth. Because of recently amended pharmaceutical regulations, however, it is likely that more antidiabetic medications soon will be added to the armamentarium of therapeutic options for youth with type 2 diabetes. Additionally, ...
There are two major types of diabetes, called type 1 and type 2. In type 1 diabetes, formerly called insulin-dependent diabetes mellitus (IDDM), or juvenile-onset diabetes mellitus, the pancreas undergoes an autoimmune attack by the body itself and is rendered incapable of making insulin. Abnor...
There are two major types of diabetes, called type 1 and type 2. In type 1 diabetes, formerly called insulin-dependent diabetes mellitus (IDDM), or juvenile-onset diabetes mellitus, the pancreas undergoes an autoimmune attack by the body itself and is rendered incapable of making insulin. Abnor...
GLP-1Glucagon-like peptide 1Glucagon-like peptide 1HbHemoglobinHemoglobindoi:10.1016/j.jpeds.2015.11.015Meehan, ColetteSilverstein, JanetElsevier Inc.Journal of PediatricsMeehan C., Silverstein J. Treatment Options for Type 2 Diabetes in Youth Remain Limited. (2015) Journal of Pediatrics...
type 1 diabetes is a continuum of stages, from genetic risk through to autoimmunity and then metabolic disease. This has been accompanied by the evolution of descriptive terminology that reflects these stages (Table1). Similarly, treatment options have moved on from monitoring and managing metabolic...
2.2. Phase 1: Context Relevance Evaluation and Instrument Translation In August 2019, an expert panel was formed to evaluate context relevance of the DEPS-R given the current clinical and cultural context for Chinese people with T1D. The panel included an endocrinologist, two diabetes clinicians, ...